Regulators, Industry Agree That Frequent Communication Is Key In Developing Breakthrough, PRIME Therapies

 
• By Joanne S. Eglovitch

EU and US FDA regulators and industry share strategies for expediting the development of breakthrough and PRIME therapies.

Communications. Business Concept Illustration. - Vector
Early Communication Needed To Expedite Development of Advanced Therapies • Source: Shutterstock

More from Manufacturing

More from Compliance